title: Dapsone efficacy and adverse events in the management of mucous membrane pemphigoid.
authors.forename: Anne M
authors.initials: AM
authors.lastname: Hegarty
authors.forename: Martyn
authors.initials: M
authors.lastname: Ormond
authors.forename: Maureen
authors.initials: M
authors.lastname: Sweeney
authors.forename: Tim
authors.initials: T
authors.lastname: Hodgson
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003622:Dapsone / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007917:Leprostatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D010390:Pemphigoid, Benign Mucous Membrane / Q000188:drug therapy*
chemical_list: D007917:Leprostatic Agents; D003622:Dapsone